Ghirardi V

No ORCID on file · 3 papers in corpus
2019
Oncotarget ·doi:10.18632/oncotarget.26803

Gynaecological sarcomas account for 3-4% of all gynaecological malignancies and have a poorer prognosis compared to gynaecological carcinomas. Pivotal treatment for early-stage uterine sarcoma is represented by total hysterectomy. Whereas o…

article 2015
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2015.08.536
review 2014
Expert opinion on pharmacotherapy ·doi:10.1517/14656566.2014.943734

INTRODUCTION: Dienogest (DNG) is an oral progestin, derivative of 19-nortestosterone, that has recently been introduced for the treatment of endometriosis. AREAS COVERED: This review examines the clinical efficacy, safety and tolerability o…